A pediatric patient with autism spectrum disorder and epilepsy using cannabinoid extracts as complementary therapy: a case report

Abstract Background The pharmacological treatment for autism spectrum disorders is often poorly tolerated and has traditionally targeted associated conditions, with limited benefit for the core social deficits. We describe the novel use of a cannabidiol-based extract that incidentally improved core...

Full description

Bibliographic Details
Main Authors: Juliana Andrea Ponton, Kim Smyth, Elias Soumbasis, Sergio Andres Llanos, Mark Lewis, Wilhelm August Meerholz, Robert Lawrence Tanguay
Format: Article
Language:English
Published: BMC 2020-09-01
Series:Journal of Medical Case Reports
Subjects:
Online Access:http://link.springer.com/article/10.1186/s13256-020-02478-7
_version_ 1818342034448056320
author Juliana Andrea Ponton
Kim Smyth
Elias Soumbasis
Sergio Andres Llanos
Mark Lewis
Wilhelm August Meerholz
Robert Lawrence Tanguay
author_facet Juliana Andrea Ponton
Kim Smyth
Elias Soumbasis
Sergio Andres Llanos
Mark Lewis
Wilhelm August Meerholz
Robert Lawrence Tanguay
author_sort Juliana Andrea Ponton
collection DOAJ
description Abstract Background The pharmacological treatment for autism spectrum disorders is often poorly tolerated and has traditionally targeted associated conditions, with limited benefit for the core social deficits. We describe the novel use of a cannabidiol-based extract that incidentally improved core social deficits and overall functioning in a patient with autism spectrum disorder, at a lower dose than has been previously reported in autism spectrum disorder. Case presentation The parents of a 15-year-old boy, of South African descent, with autism spectrum disorder, selective mutism, anxiety, and controlled epilepsy, consulted a medical cannabis physician to trial cannabis extract to replace seizure medications. Incidentally, at a very low cannabidiol-based extract dose, he experienced unanticipated positive effects on behavioral symptoms and core social deficits. Conclusion This case report provides evidence that a lower than previously reported dose of a phytocannabinoid in the form of a cannabidiol-based extract may be capable of aiding in autism spectrum disorder-related behavioral symptoms, core social communication abilities, and comorbid anxiety, sleep difficulties, and weight control. Further research is needed to elucidate the clinical role and underlying biological mechanisms of action of cannabidiol-based extract in patients with autism spectrum disorder.
first_indexed 2024-12-13T16:08:16Z
format Article
id doaj.art-c75a0f248c004b51bfebfdb45773de22
institution Directory Open Access Journal
issn 1752-1947
language English
last_indexed 2024-12-13T16:08:16Z
publishDate 2020-09-01
publisher BMC
record_format Article
series Journal of Medical Case Reports
spelling doaj.art-c75a0f248c004b51bfebfdb45773de222022-12-21T23:39:00ZengBMCJournal of Medical Case Reports1752-19472020-09-011411710.1186/s13256-020-02478-7A pediatric patient with autism spectrum disorder and epilepsy using cannabinoid extracts as complementary therapy: a case reportJuliana Andrea Ponton0Kim Smyth1Elias Soumbasis2Sergio Andres Llanos3Mark Lewis4Wilhelm August Meerholz5Robert Lawrence Tanguay6Caleo HealthAlberta Children’s HospitalCaleo HealthCaleo HealthCaleo HealthCaleo HealthCaleo HealthAbstract Background The pharmacological treatment for autism spectrum disorders is often poorly tolerated and has traditionally targeted associated conditions, with limited benefit for the core social deficits. We describe the novel use of a cannabidiol-based extract that incidentally improved core social deficits and overall functioning in a patient with autism spectrum disorder, at a lower dose than has been previously reported in autism spectrum disorder. Case presentation The parents of a 15-year-old boy, of South African descent, with autism spectrum disorder, selective mutism, anxiety, and controlled epilepsy, consulted a medical cannabis physician to trial cannabis extract to replace seizure medications. Incidentally, at a very low cannabidiol-based extract dose, he experienced unanticipated positive effects on behavioral symptoms and core social deficits. Conclusion This case report provides evidence that a lower than previously reported dose of a phytocannabinoid in the form of a cannabidiol-based extract may be capable of aiding in autism spectrum disorder-related behavioral symptoms, core social communication abilities, and comorbid anxiety, sleep difficulties, and weight control. Further research is needed to elucidate the clinical role and underlying biological mechanisms of action of cannabidiol-based extract in patients with autism spectrum disorder.http://link.springer.com/article/10.1186/s13256-020-02478-7AutismCannabidiol extractPhytocannabinoidsComplementary treatment
spellingShingle Juliana Andrea Ponton
Kim Smyth
Elias Soumbasis
Sergio Andres Llanos
Mark Lewis
Wilhelm August Meerholz
Robert Lawrence Tanguay
A pediatric patient with autism spectrum disorder and epilepsy using cannabinoid extracts as complementary therapy: a case report
Journal of Medical Case Reports
Autism
Cannabidiol extract
Phytocannabinoids
Complementary treatment
title A pediatric patient with autism spectrum disorder and epilepsy using cannabinoid extracts as complementary therapy: a case report
title_full A pediatric patient with autism spectrum disorder and epilepsy using cannabinoid extracts as complementary therapy: a case report
title_fullStr A pediatric patient with autism spectrum disorder and epilepsy using cannabinoid extracts as complementary therapy: a case report
title_full_unstemmed A pediatric patient with autism spectrum disorder and epilepsy using cannabinoid extracts as complementary therapy: a case report
title_short A pediatric patient with autism spectrum disorder and epilepsy using cannabinoid extracts as complementary therapy: a case report
title_sort pediatric patient with autism spectrum disorder and epilepsy using cannabinoid extracts as complementary therapy a case report
topic Autism
Cannabidiol extract
Phytocannabinoids
Complementary treatment
url http://link.springer.com/article/10.1186/s13256-020-02478-7
work_keys_str_mv AT julianaandreaponton apediatricpatientwithautismspectrumdisorderandepilepsyusingcannabinoidextractsascomplementarytherapyacasereport
AT kimsmyth apediatricpatientwithautismspectrumdisorderandepilepsyusingcannabinoidextractsascomplementarytherapyacasereport
AT eliassoumbasis apediatricpatientwithautismspectrumdisorderandepilepsyusingcannabinoidextractsascomplementarytherapyacasereport
AT sergioandresllanos apediatricpatientwithautismspectrumdisorderandepilepsyusingcannabinoidextractsascomplementarytherapyacasereport
AT marklewis apediatricpatientwithautismspectrumdisorderandepilepsyusingcannabinoidextractsascomplementarytherapyacasereport
AT wilhelmaugustmeerholz apediatricpatientwithautismspectrumdisorderandepilepsyusingcannabinoidextractsascomplementarytherapyacasereport
AT robertlawrencetanguay apediatricpatientwithautismspectrumdisorderandepilepsyusingcannabinoidextractsascomplementarytherapyacasereport
AT julianaandreaponton pediatricpatientwithautismspectrumdisorderandepilepsyusingcannabinoidextractsascomplementarytherapyacasereport
AT kimsmyth pediatricpatientwithautismspectrumdisorderandepilepsyusingcannabinoidextractsascomplementarytherapyacasereport
AT eliassoumbasis pediatricpatientwithautismspectrumdisorderandepilepsyusingcannabinoidextractsascomplementarytherapyacasereport
AT sergioandresllanos pediatricpatientwithautismspectrumdisorderandepilepsyusingcannabinoidextractsascomplementarytherapyacasereport
AT marklewis pediatricpatientwithautismspectrumdisorderandepilepsyusingcannabinoidextractsascomplementarytherapyacasereport
AT wilhelmaugustmeerholz pediatricpatientwithautismspectrumdisorderandepilepsyusingcannabinoidextractsascomplementarytherapyacasereport
AT robertlawrencetanguay pediatricpatientwithautismspectrumdisorderandepilepsyusingcannabinoidextractsascomplementarytherapyacasereport